AstraZeneca may resume COVID-19 vaccine trials next week - FT

British drugmaker AstraZeneca Plc could resume trials for its experimental coronavirus vaccine next week, the Financial Times reported on Wednesday, citing people associated with the trials. (https://on.ft.com/3m4ytwt)

The London-listed firm had to pause global trials of its potential vaccine for COVID-19 after an unexplained illness in a participant, which sent its shares lower as the move was seen as dimming prospects for an early rollout.

AstraZeneca did not immediately respond to a Reuters request for comment.